LONDON--(BUSINESS WIRE)--The global dermatological drugs market 2018-2022 is expected to post a CAGR of more than 11% during the forecast period, according to the latest market research report by Technavio.
A key factor driving the growth of the market is the need for safe and stable drugs that require minimal monitoring. Presently, most drugs used to treat severe dermatological conditions are associated with neuropsychiatric adverse effects. They are dose and duration dependent, and hence require systematic monitoring for identifying adverse effects.
This market research report on the global dermatological drugs market 2018-2022 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
In this report, Technavio highlights the increase in prices of dermatological drugs as one of the key emerging trends in the global dermatological drugs market:
Global dermatological drugs market: Increase in prices of dermatological drugs
The increase in the price of dermatological drugs is partially driven by consumer demand and faster approvals of new drugs. In dermatology, topicals are the most cost-effective therapy, followed by small molecules. However, manufacturers apply pricing strategies such as discounted price through contracts with buyers and through copay coupon cards.
“The launch of biosimilars is expected to affect the innovative prices, as well as reduce prices for follow-on biologics. A strategy adopted by manufacturers of newer biologics is targeting specialized niche markets to justify their product price,” says a senior analyst at Technavio.
Global dermatological drugs market: Segmentation analysis
This market research report segments the global dermatological drugs market by product (biologics and small molecules) and geographical regions (APAC, EMEA, and the Americas).
The Americas led the market in 2017 with a market share of close to 48%, followed by APAC and EMEA respectively. The dominance of the Americas can be attributed to the increasing prevalence of skin diseases in the region.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
